Business Description
Enimmune Corp
ISIN : TW0006564008
Total Employee Number:
33Description
Enimmune Corp is primarily engaged in the research and development and trading of vaccines, testing reagents and biotechnology services, etc., as well as trading of related western medicines.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.44 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 1.15 | |||||
Debt-to-EBITDA | -1.13 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.49 | |||||
Beneish M-Score | -1.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -39 | |||||
3-Year EBITDA Growth Rate | 19.6 | |||||
3-Year EPS without NRI Growth Rate | 15.4 | |||||
3-Year FCF Growth Rate | 13.4 | |||||
3-Year Book Growth Rate | -36.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 58.14 | |||||
9-Day RSI | 55.59 | |||||
14-Day RSI | 52.46 | |||||
3-1 Month Momentum % | -16.92 | |||||
6-1 Month Momentum % | -22.3 | |||||
12-1 Month Momentum % | 0.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.16 | |||||
Quick Ratio | 1.08 | |||||
Cash Ratio | 0.9 | |||||
Days Inventory | 249.63 | |||||
Days Sales Outstanding | 87.42 | |||||
Days Payable | 42.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | 8.06 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 16.63 | |||||
Operating Margin % | -387.64 | |||||
Net Margin % | -341.01 | |||||
EBITDA Margin % | -314.26 | |||||
FCF Margin % | -305.91 | |||||
OCF Margin % | -297.24 | |||||
ROE % | -65.9 | |||||
ROA % | -28.98 | |||||
ROIC % | -68.04 | |||||
3-Year ROIIC % | 120.74 | |||||
ROC (Joel Greenblatt) % | -1528.22 | |||||
ROCE % | -52.44 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 25.15 | |||||
PB Ratio | 8.1 | |||||
Price-to-Tangible-Book | 24 | |||||
EV-to-EBIT | -7.08 | |||||
EV-to-EBITDA | -7.51 | |||||
EV-to-Revenue | 23.58 | |||||
EV-to-FCF | -7.29 | |||||
Price-to-GF-Value | 0.79 | |||||
| Price-to-Net-Current-Asset-Value | 105 | |||||
Earnings Yield (Greenblatt) % | -14.13 | |||||
FCF Yield % | -12.17 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enimmune Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 48.194 | ||
| EPS (TTM) (NT$) | -2.28 | ||
| Beta | 0.185 | ||
| 3-Year Sharpe Ratio | -1.43 | ||
| 3-Year Sortino Ratio | -1.5 | ||
| Volatility % | 28.77 | ||
| 14-Day RSI | 52.46 | ||
| 14-Day ATR (NT$) | 0.611539 | ||
| 20-Day SMA (NT$) | 16.345 | ||
| 12-1 Month Momentum % | 0.31 | ||
| 52-Week Range (NT$) | 15.4 - 23.9 | ||
| Shares Outstanding (Mil) | 72.13 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enimmune Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enimmune Corp Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enimmune Corp Frequently Asked Questions
What is Enimmune Corp(ROCO:6564)'s stock price today?
The current price of ROCO:6564 is NT$16.80. The 52 week high of ROCO:6564 is NT$23.90 and 52 week low is NT$15.40.
When is next earnings date of Enimmune Corp(ROCO:6564)?
The next earnings date of Enimmune Corp(ROCO:6564) is .
Does Enimmune Corp(ROCO:6564) pay dividends? If so, how much?
Enimmune Corp(ROCO:6564) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Enimmune Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers